Literature DB >> 26404035

Tilt table testing in neurology and clinical neurophysiology.

D P Saal1, R D Thijs2, J G van Dijk3.   

Abstract

Reflex syncope is responsible for 1-6% of hospital admissions and the economic burden of syncope is huge. A considerable part of these high costs is still spent on tests that are not indicated. Till now few neurologists have taken an interest in syncope and tilt table testing (TTT). However, reflex syncope and epilepsy are often in each other's differential diagnosis and require a similar emphasis on history taking and deductive reasoning. A TTT can be helpful for diagnosis and treatment. The pathophysiological rationale behind the TTT is the fact that it uses gravity to provoke a downwards shift of blood that in turn triggers syncope. Various indications and methods of the TTT are discussed in this paper.
Copyright © 2015 International Federation of Clinical Neurophysiology. Published by Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Head-up tilt; Orthostatic hypotension; Reflex syncope; Syncope; Tilt table test

Mesh:

Year:  2015        PMID: 26404035     DOI: 10.1016/j.clinph.2015.07.037

Source DB:  PubMed          Journal:  Clin Neurophysiol        ISSN: 1388-2457            Impact factor:   3.708


  8 in total

Review 1.  Autonomic uprising: the tilt table test in autonomic medicine.

Authors:  William P Cheshire; David S Goldstein
Journal:  Clin Auton Res       Date:  2019-03-05       Impact factor: 4.435

Review 2.  Recommendations for tilt table testing and other provocative cardiovascular autonomic tests in conditions that may cause transient loss of consciousness : Consensus statement of the European Federation of Autonomic Societies (EFAS) endorsed by the American Autonomic Society (AAS) and the European Academy of Neurology (EAN).

Authors:  Roland D Thijs; Michele Brignole; Cristian Falup-Pecurariu; Alessandra Fanciulli; Roy Freeman; Pietro Guaraldi; Jens Jordan; Mario Habek; Max Hilz; Anne Pavy-Le Traon; Iva Stankovic; Walter Struhal; Richard Sutton; Gregor Wenning; J Gert Van Dijk
Journal:  Clin Auton Res       Date:  2021-03-19       Impact factor: 4.435

Review 3.  Functional Imaging of Autonomic Regulation: Methods and Key Findings.

Authors:  Paul M Macey; Jennifer A Ogren; Rajesh Kumar; Ronald M Harper
Journal:  Front Neurosci       Date:  2016-01-26       Impact factor: 4.677

4.  Cerebral Blood Flow, Heart Rate, and Blood Pressure Patterns during the Tilt Test in Common Orthostatic Syndromes.

Authors:  Peter Novak
Journal:  Neurosci J       Date:  2016-07-20

5.  Giant axonal neuropathy: cross-sectional analysis of a large natural history cohort.

Authors:  Diana X Bharucha-Goebel; Gina Norato; Dimah Saade; Eduardo Paredes; Victoria Biancavilla; Sandra Donkervoort; Rupleen Kaur; Tanya Lehky; Margaret Fink; Diane Armao; Steven J Gray; Melissa Waite; Sarah Debs; Gilberto Averion; Ying Hu; Wadih M Zein; A Reghan Foley; Minal Jain; Carsten G Bönnemann
Journal:  Brain       Date:  2021-11-29       Impact factor: 15.255

6.  Development and evaluation of a novel system for inducing orthostatic challenge by tilt tests and lower body negative pressure.

Authors:  Łukasz Dziuda; Mariusz Krej; Maciej Śmietanowski; Aleksander Sobotnicki; Mariusz Sobiech; Piotr Kwaśny; Anna Brzozowska; Paulina Baran; Krzysztof Kowalczuk; Franciszek W Skibniewski
Journal:  Sci Rep       Date:  2018-05-17       Impact factor: 4.379

7.  Quantifying resilience of humans and other animals.

Authors:  Marten Scheffer; J Elizabeth Bolhuis; Denny Borsboom; Timothy G Buchman; Sanne M W Gijzel; Dave Goulson; Jan E Kammenga; Bas Kemp; Ingrid A van de Leemput; Simon Levin; Carmel Mary Martin; René J F Melis; Egbert H van Nes; L Michael Romero; Marcel G M Olde Rikkert
Journal:  Proc Natl Acad Sci U S A       Date:  2018-10-29       Impact factor: 11.205

8.  New hemodynamic criteria to separate classical orthostatic hypotension from vasovagal syncope.

Authors:  Maryam Ghariq; Fabian I Kerkhof; Robert H Reijntjes; Roland D Thijs; J Gert van Dijk
Journal:  Ann Clin Transl Neurol       Date:  2021-06-24       Impact factor: 4.511

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.